Zepp Health Corp. Depositary Receipt (ZEPP) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 24	-$0.12	-$0.76	-533.3%	—	$5.6M	—
Q4 23	$0.17	$0.03	-82.4%	—	$92.2M	—
Q3 23	$0.06	$0.14	+133.3%	—	$83.1M	—
Q2 23	-$0.05	-$0.53	-960.0%	—	$92.4M	—
Q1 23	-$0.1	-$1.04	-940.0%	—	$93.8M	—
Q4 22	-$0.08	-$0.58	-625.0%	—	$169.5M	—
Q3 22	$0.19	-$0.08	-142.1%	—	$169.2M	—
Q2 22	-$0.44	-$0.9	-104.5%	—	$165.4M	—
Q1 22	$0.06	-$0.73	-1316.7%	—	$119.1M	—
Q4 21	$0.88	$0.5	-43.2%	—	$271.5M	—
Q3 21	$0.61	$0.61	0.0%	—	$248.2M	—
Q2 21	$0.52	$1.24	+138.5%	—	$283.9M	—
Q1 21	$0.12	-$0.29	-341.7%	—	$174.3M	—
Q4 20	$0.88	$1.21	+37.5%	—	$331.2M	—
Q3 20	$1.68	$1.12	-33.3%	—	$327.4M	—
Q2 20	$0.17	$0.17	0.0%	—	$160.4M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$2.56	—	—	$258.9M	—
FY24	—	-$4.64	—	—	$182.6M	—
FY23	—	-$1.96	—	—	$352M	—
FY22	—	-$2.71	—	—	$600.5M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$224.2M	$313.8M	$529.9M	$830.7M	$984.7M	$980.5M	$600.5M	$352M	$182.6M	$258.9M
YoY change	+62.3%	+40%	+68.9%	+56.8%	+18.5%	-0.42%	-38.8%	-41.4%	-48.1%	+41.8%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	224.2M	313.8M	529.9M	830.7M	984.7M	980.5M	600.5M	352M	182.6M	258.9M
Cost of revenue	184.4M	238.1M	393.4M	620.9M	780.7M	775.7M	484.1M	259.2M	112.4M	159.7M
Gross profit	39.8M	75.8M	136.6M	209.8M	204M	204.8M	116.4M	92.8M	70.2M	99.2M
Gross margin	17.7%	24.1%	25.8%	25.3%	20.7%	20.9%	19.4%	26.4%	38.5%	38.3%
Research & development	19.1M	23.6M	38.3M	61.6M	82.3M	80.8M	75M	51M	46.2M	45.3M
Selling, general & administrative	18.8M	24.3M	45.1M	61.5M	95M	109.3M	100.9M	71M	71.3M	83.1M
Operating expenses	37.8M	47.9M	83.4M	123.1M	177.3M	190.1M	175.9M	122M	117.5M	128.4M
Operating income	1.9M	27.9M	53.2M	86.7M	26.7M	14.7M	-59.5M	-29.2M	-47.3M	-29.2M
Operating margin	0.86%	8.88%	10%	10.4%	2.71%	1.5%	-9.9%	-8.3%	-25.9%	-11.3%
Non-operating income, net	2.1M	1.1M	1.4M	1.8M	10.4M	6.4M	11.9M	-549.5K	-8.8M	-2.1M
Pretax income	4.2M	29.4M	56.2M	93.2M	40.7M	16.7M	-54M	-33.4M	-57.9M	-35.5M
Income tax	444.7K	4.2M	7.6M	11.1M	4.8M	1.7M	-9.5M	-2.2M	13.7M	2.5M
Net income	3.4M	25.6M	48.9M	81.9M	35.2M	21.5M	-41.9M	-30M	-75.8M	-40.1M
Net margin	1.54%	8.16%	9.23%	9.86%	3.57%	2.19%	-6.98%	-8.52%	-41.5%	-15.5%
EBITDA	2.3M	28.1M	54M	95.8M	37.7M	29.8M	-42.8M	-19M	-39.2M	-23.1M
EPS	-0.12	0.48	3.49	5.37	2.25	1.38	-2.71	-1.96	-4.64	-2.56
Diluted EPS	-0.12	0.48	3.14	5.12	2.16	1.31	-2.71	-1.96	-4.64	-2.56

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	83.1M	92.2M	5.6M	40.6M	42.5M	59.5M	38.5M	59.4M	75.8M	85.2M	51.5M	63.5M
Cost of revenue	54.9M	61M	3.5M	24.3M	25.2M	37.6M	24.2M	37.9M	46.9M	50.8M	32.1M	39.8M
Gross profit	28.2M	31.2M	2.1M	16.4M	17.2M	21.9M	14.4M	21.5M	28.9M	34.4M	19.4M	23.7M
Gross margin	33.9%	33.8%	36.8%	40.3%	40.6%	36.8%	37.3%	36.2%	38.2%	40.4%	37.7%	37.4%
Research & development	10.4M	12.4M	1.9M	10.8M	10.9M	11.1M	12.4M	11.2M	10.8M	11M	13.1M	11.5M
Selling, general & administrative	16.4M	18.9M	2.4M	15.4M	18.9M	19.8M	20.4M	16.4M	19M	27.3M	24M	24.5M
Operating expenses	26.8M	31.3M	4.3M	26.2M	29.8M	30.9M	32.7M	27.6M	29.8M	38.3M	37.1M	36M
Operating income	1.4M	-100K	-2.2M	-9.9M	-12.5M	-8.9M	-18.4M	-6.1M	-884K	-3.9M	-17.7M	-12.3M
Operating margin	1.66%	-0.11%	-39.6%	-24.3%	-29.5%	-15%	-47.7%	-10.3%	-1.17%	-4.55%	-34.3%	-19.4%
Non-operating income, net	-196K	-956K	303.8K	-173K	91K	-10.9M	-121K	59K	774K	-2.8M	25K	3M
Pretax income	383K	-1.8M	-2M	-10.5M	-12.8M	-20.5M	-19.3M	-7M	-1.3M	-7.9M	-19M	-10.5M
Income tax	66K	2.7M	10K	47K	0	13.6M	110K	242K	117K	2.1M	214K	114K
Net income	266K	-2M	-2.1M	-10.8M	-13.3M	-36.9M	-19.7M	-7.7M	-1.6M	-11M	-19.6M	-11.3M
Net margin	0.32%	-2.16%	-36.8%	-26.7%	-31.2%	-62%	-51.2%	-13%	-2.13%	-12.9%	-38.1%	-17.8%
EBITDA	2M	905K	-2.1M	-8.8M	-11.7M	-8.9M	-17.8M	-5.7M	-238K	-3.9M	-17.4M	-11.9M
EPS	0.02	-0.07	-0.92	-0.64	-0.8	-2.24	-1.28	-0.48	-0.16	-0.64	-1.28	-0.64
Diluted EPS	0.02	-0.07	-0.92	-0.64	-0.8	-2.24	-1.28	-0.48	-1.6	-0.64	-1.28	-11.5

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	—	—	—	5.3B	2.3B	648.4M	628.9M	—	428.4M	428.4M
Enterprise value	—	—	—	—	5.1B	2.3B	765.2M	685.9M	—	600.3M	600.3M
Shares outstanding	107.9M	107.9M	96.2M	110.6M	112.8M	114.5M	111.8M	110.7M	16.2M	15.9M	15.9M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	152	107.6	—	—	—	—	—
P/S	—	—	—	—	5.43	2.36	1.08	1.79	—	1.65	1.65
P/B	—	—	—	—	12.8	5.02	1.67	1.78	—	2	2
EV/EBITDA	—	—	—	—	135.3	76.6	-17.9	-36.2	—	-26	-26
EV/Sales	—	—	—	—	5.19	2.33	1.27	1.95	—	2.32	2.32
Earnings yield	—	—	—	—	0.66%	0.93%	—	—	—	—	—
FCF yield	—	—	—	—	0.21%	-1.94%	-17.8%	6.43%	—	-6.18%	-6.18%

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	17.7%	24.1%	25.8%	25.3%	20.7%	20.9%	19.4%	26.4%	38.5%	38.3%	38.3%
Operating margin	0.86%	8.88%	10%	10.4%	2.71%	1.5%	-9.9%	-8.3%	-25.9%	-11.3%	-11.3%
Net margin	1.54%	8.16%	9.23%	9.86%	3.57%	2.19%	-6.98%	-8.52%	-41.5%	-15.5%	-15.5%
ROE	79.3%	73.2%	18.6%	23%	8.41%	4.67%	-10.8%	-8.49%	-30%	-18.7%	-18.7%
ROA	2.46%	11.4%	10.3%	11.1%	3.89%	2.25%	-5.49%	-4.71%	-14.3%	-7.09%	-7.09%
ROIC	-10%	-133.6%	122.1%	67.7%	13.2%	3.07%	-11.8%	-7.12%	-13.8%	-7.56%	-7.56%
Return on tangible assets	2.47%	11.6%	10.8%	11.5%	4.19%	2.41%	-5.91%	-5.02%	-15.3%	-7.73%	-7.73%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.36	1.48	2.06	1.77	1.73	1.83	1.77	2.04	1.29	1.02	1.02
Quick ratio	1.05	1.19	1.71	1.41	1.29	1.25	1.16	1.49	1	0.77	0.77
Debt / equity	0.42	0.15	0.02	0.04	0.27	0.45	0.64	0.55	0.72	1.07	1.07
Debt / assets	0.01	0.02	0.01	0.02	0.12	0.22	0.33	0.31	0.34	0.41	0.41
Net debt / EBITDA	-9.49	-1.88	-4.17	-2.55	-6.36	-0.96	-2.73	-3.01	-2.3	-7.44	-7.44
Interest coverage	—	—	—	—	12.7	3.38	-5.54	-3.96	-9.43	-5.22	-5.22
Effective tax rate	10.7%	14.4%	13.5%	11.9%	11.7%	10.1%	0%	0%	0%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	2.08	2.91	5.51	7.51	8.73	8.57	5.37	3.18	11.3	16.3	16.3
EPS (basic)	-0.12	0.48	3.49	5.37	2.25	1.38	-2.71	-1.96	-4.64	-2.56	-2.56
EPS (diluted)	-0.12	0.48	3.14	5.12	2.16	1.31	-2.71	-1.96	-4.64	-2.56	-2.56
Book value per share	0.04	0.32	2.74	3.23	3.71	4.02	3.48	3.19	15.6	13.5	13.5
FCF per share	0.01	0.31	0.97	0.49	0.1	-0.39	-1.03	0.37	-1.6	-1.66	-1.66
Cash per share	0.22	0.54	2.4	2.35	3.12	2.05	1.19	1.26	5.69	3.59	3.59
Capex per share	0.01	0.03	0.03	0.04	0.11	0.06	0.01	0	0.04	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	0.66%	1.04%	0.47%	0.59%	1.3%	0.7%	0.2%	0%	0.39%	—	—
Capex / operating cash flow	2.89%	9.46%	3.15%	9.89%	19.7%	-22.1%	-0.85%	0.02%	-2.72%	—	—
Payout ratio	—	0%	0%	0.79%	0%	0%	-13.8%	0%	0%	—	—
Dividend yield	—	—	—	—	0%	0%	0.89%	0%	—	—	—

Yield

—

trailing twelve months

Frequency

—

Last dividend

$0.40

ex-dividend Mar 25, 2022

Payout ratio

—

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Mar 25, 2022	$0.40

Split history

Date	Ratio
Sep 16, 2024	1:4

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$83.1M	$92.2M	$5.6M	$40.6M	$42.5M	$59.5M	$38.5M	$59.4M	$75.8M	$85.2M	$51.5M	$63.5M
YoY change	-50.9%	-45.6%	-94%	-56%	-48.9%	-35.4%	+589.2%	+46.2%	+78.5%	+43%	+33.8%	+6.93%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	23.4M	58.2M	231M	260.2M	351.5M	234.2M	133.5M	139M	92.1M	57M
Receivables	2.8M	5M	8.6M	27M	45.6M	84.3M	98.9M	60.8M	63M	66.9M
Inventory	27.7M	38.3M	70.4M	127.7M	186.4M	196M	148.1M	85M	56.8M	72.8M
Total current assets	123.8M	198.4M	415.4M	627.8M	739M	616.7M	428.8M	317.2M	251.6M	293.5M
Property, plant & equipment	1.6M	1.6M	3M	22M	39.3M	32.6M	19M	10.9M	5.6M	2.6M
Goodwill & intangibles	352.3K	3.5M	20.3M	26.2M	63.6M	61.7M	54.9M	39M	33.3M	46.4M
Total assets	140.1M	224.5M	473.7M	739.6M	903.6M	954.7M	763.5M	636.5M	528.6M	564.8M
Accounts payable	75.5M	108.4M	154.7M	285.8M	298.7M	206.7M	66.2M	37.3M	51.1M	80.8M
Short-term debt	1.8M	5.4M	5.7M	5M	84.6M	80.3M	146.5M	72.7M	104.9M	168.4M
Total current liabilities	91.4M	134.4M	201.7M	354.7M	427M	337.6M	241.9M	155.4M	195.4M	286.8M
Long-term debt	—	—	0	10.9M	27M	125.2M	103.8M	123.4M	77.2M	60.6M
Total liabilities	135.8M	189.5M	210.6M	382.6M	485.7M	494.5M	374.3M	283.2M	275.9M	350.3M
Shareholders' equity	4.3M	34.9M	263.1M	357M	417.9M	460.2M	389.2M	353.3M	252.7M	214.5M
Total debt	1.8M	5.4M	5.7M	15.9M	111.6M	205.5M	250.3M	196.1M	182.1M	229M
Net debt	-20.2M	-50.7M	-203.9M	-241.8M	-236.4M	-24.9M	121.8M	62.2M	91.1M	171.9M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	—	—	—	—	—	—	—	—	62.7M	57M	52.4M	69.7M
Receivables	—	—	—	—	—	—	—	—	82.8M	66.9M	56.2M	75.5M
Inventory	—	—	—	—	—	—	—	—	87.7M	72.8M	62.8M	62.4M
Total current assets	—	—	—	—	—	—	—	—	311.8M	293.5M	259.3M	282.5M
Property, plant & equipment	—	—	—	—	—	—	—	—	8M	2.6M	7.9M	7.6M
Goodwill & intangibles	—	—	—	—	—	—	—	—	46.6M	46.4M	45.6M	44.8M
Total assets	—	—	—	—	—	—	—	—	586.4M	564.8M	532.6M	559.7M
Accounts payable	—	—	—	—	—	—	—	—	105.1M	80.8M	59.2M	88M
Short-term debt	—	—	—	—	—	—	—	—	139.5M	168.4M	198.1M	188.5M
Total current liabilities	—	—	—	—	—	—	—	—	285.9M	286.8M	294.3M	314.4M
Long-term debt	—	—	—	—	—	—	—	—	70.8M	60.6M	41.4M	57.5M
Total liabilities	—	—	—	—	—	—	—	—	360.1M	350.3M	338.4M	374.7M
Shareholders' equity	—	—	—	—	—	—	—	—	226.3M	214.5M	194.2M	185M
Total debt	—	—	—	—	—	—	—	—	210.3M	229M	239.4M	246M
Net debt	—	—	—	—	—	—	—	—	148.6M	171.9M	187M	176.3M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	3.4M	25.6M	48.9M	81.9M	35.2M	21.5M	-41.9M	-30M	-75.8M	-40.1M
Depreciation & amortization	345.5K	569.3K	903.6K	2.5M	4.2M	8.1M	8.5M	7.7M	5M	4.5M
Stock-based compensation	8.3M	9.6M	19.6M	7.9M	10M	13M	7.1M	8.4M	4.8M	2.5M
Change in working capital	-16M	1.6M	13.6M	-43.5M	10M	-77.1M	-108.4M	41.7M	25.1M	-5.1M
Operating cash flow	51.2M	34.5M	79.1M	49.5M	65.1M	-30.8M	-138.2M	30M	-26M	-25.7M
Capital expenditure	-1.5M	-3.3M	-2.5M	-4.9M	-12.8M	-6.8M	-1.2M	6.2K	-707K	—
Investing cash flow	-14.1M	-5.9M	-39.7M	-14.4M	-31.5M	-166.7M	-5.9M	4.6M	-2.5M	1.7M
Dividends paid	—	0	0	-648.6K	0	0	-5.8M	0	0	—
Share repurchases	0	0	-1.2M	0	0	-2.2M	-7.7M	-2.5M	-2.3M	-1.2M
Financing cash flow	11.4M	23.1M	82.4M	-16.5M	651.1M	85.6M	41.9M	-41.6M	477K	24.8M
Net change in cash	48.5M	51.6M	121.8M	18.7M	684.7M	-111.9M	-102.2M	-7M	-28M	812K
Free cash flow	830.8K	33.2M	92.8M	54.6M	11.1M	-44.8M	-115.6M	40.5M	-25.9M	-26.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q4 16	Q4 17
Net income	6.3M	11.3M
Depreciation & amortization	186.4K	196.1K
Stock-based compensation	1.8M	2.3M
Change in working capital	-36.3M	-29.2M
Operating cash flow	-14.4M	-14.6M
Capital expenditure	-345.8K	-2.9M
Investing cash flow	-7.5M	-5.1M
Dividends paid	—	—
Share repurchases	—	—
Financing cash flow	11.4M	-9.9M
Net change in cash	-10.5M	-29.6M
Free cash flow	-6.8M	-16.9M

Zepp Health Corp. Depositary Receipt Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Split history

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement